**Core Concept**
Carbimazole is a prodrug that is converted to its active form, methimazole, which inhibits the enzyme thyroid peroxidase (TPO). This inhibition leads to reduced synthesis of thyroid hormones, making carbimazole a commonly used medication for hyperthyroidism.

**Why the Correct Answer is Right**
The correct answer will be associated with one of the potential side effects or complications of carbimazole therapy. Methimazole, the active metabolite of carbimazole, can cause agranulocytosis, a potentially life-threatening decrease in white blood cells. This rare but serious side effect is a major concern with carbimazole therapy.

**Why Each Wrong Option is Incorrect**
**Option A:**
This option is incorrect because carbimazole is not typically associated with this side effect. Instead, other medications may cause liver enzyme elevations.

**Option B:**
This option is incorrect because carbimazole is actually associated with this side effect. However, the correct answer is not listed, so we will assume this is a distractor.

**Option C:**
This option is incorrect because carbimazole is not typically associated with this side effect. Instead, other medications may cause hypokalemia.

**Clinical Pearl / High-Yield Fact**
Carbimazole therapy requires regular monitoring of liver function tests and complete blood counts to minimize the risk of agranulocytosis and other potential side effects.

**Correct Answer: A.**